Keurig Dr Pepper (NASDAQ:KDP) Given New $42.00 Price Target at UBS Group

Keurig Dr Pepper (NASDAQ:KDP) had its target price boosted by equities researchers at UBS Group from $40.00 to $42.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group’s price objective would indicate a potential upside of 18.61% from the company’s previous close.

Several other research analysts have also commented on KDP. Morgan Stanley upgraded Keurig Dr Pepper from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $38.00 to $40.00 in a report on Tuesday, April 1st. TD Cowen reduced their target price on shares of Keurig Dr Pepper from $39.00 to $36.00 and set a “hold” rating on the stock in a research note on Wednesday, January 8th. Argus assumed coverage on shares of Keurig Dr Pepper in a research note on Wednesday. They issued a “buy” rating and a $40.00 price target for the company. JPMorgan Chase & Co. lifted their price target on shares of Keurig Dr Pepper from $37.00 to $40.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. Finally, Piper Sandler upgraded Keurig Dr Pepper from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $35.00 to $40.00 in a report on Wednesday, April 9th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, Keurig Dr Pepper presently has a consensus rating of “Moderate Buy” and an average target price of $39.21.

Keurig Dr Pepper Stock Performance

KDP opened at $35.41 on Thursday. Keurig Dr Pepper has a twelve month low of $30.12 and a twelve month high of $38.28. The firm has a market capitalization of $48.04 billion, a PE ratio of 21.46, a PEG ratio of 2.42 and a beta of 0.54. The company has a current ratio of 0.53, a quick ratio of 0.36 and a debt-to-equity ratio of 0.50. The firm’s 50-day moving average price is $33.82 and its 200 day moving average price is $33.28.

Keurig Dr Pepper (NASDAQ:KDP) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.01. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The business had revenue of $4.07 billion during the quarter, compared to analyst estimates of $4.01 billion. During the same period in the prior year, the business earned $0.55 earnings per share. The business’s revenue was up 5.2% compared to the same quarter last year. As a group, sell-side analysts expect that Keurig Dr Pepper will post 1.92 EPS for the current fiscal year.

Insider Activity

In related news, major shareholder Bevco B.V. Jab acquired 3,619,600 shares of the firm’s stock in a transaction dated Wednesday, January 29th. The stock was acquired at an average price of $33.34 per share, for a total transaction of $120,677,464.00. Following the purchase, the insider now owns 218,063,479 shares of the company’s stock, valued at $7,270,236,389.86. This represents a 1.69 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Angela A. Stephens sold 7,350 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $34.17, for a total transaction of $251,149.50. Following the sale, the vice president now owns 74,587 shares in the company, valued at $2,548,637.79. The trade was a 8.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 84,421,350 shares of company stock valued at $2,757,137,010. 1.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Keurig Dr Pepper by 23.6% during the fourth quarter. Vanguard Group Inc. now owns 119,587,162 shares of the company’s stock worth $3,841,140,000 after purchasing an additional 22,856,757 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Keurig Dr Pepper by 36.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company’s stock worth $1,755,564,000 after acquiring an additional 14,473,054 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its holdings in shares of Keurig Dr Pepper by 65.0% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 21,219,771 shares of the company’s stock valued at $681,579,000 after acquiring an additional 8,363,192 shares during the last quarter. Norges Bank purchased a new stake in Keurig Dr Pepper during the fourth quarter worth approximately $197,819,000. Finally, Wellington Management Group LLP lifted its stake in Keurig Dr Pepper by 10.3% during the fourth quarter. Wellington Management Group LLP now owns 60,602,781 shares of the company’s stock worth $1,946,561,000 after purchasing an additional 5,646,179 shares during the last quarter. Institutional investors and hedge funds own 93.99% of the company’s stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.